Somi Health review

Somi provides a visible prescription pathway and names pharmacy contacts, but its public terms leave important purchase questions unresolved. Treat the low monthly plan equivalents as an invitation to request a complete written quote, with the guarantee, cancellation deadline and treating organization clarified before payment.

Somi is an online weight-care service marketing compounded semaglutide and tirzepatide, with an intake reviewed before prescribing. Its offer can appeal to someone seeking a medication-and-care bundle rather than separate appointments and pharmacy shopping. However, identifying the actual care relationship requires more than reading the brand name. The terms and telehealth consent use Somi Health LLC, while the site footer says Somi Health Inc. The terms also refer to affiliated professional entities without establishing the practice assigned to an individual patient. Those descriptions do not prove that the two corporate names are interchangeable. Ask which entity contracts with you, which medical organization holds the records and who supervises the prescribing relationship. The consent names Emerald Compounding Pharmacy and CASA Pharma RX as pharmacy contacts. This is a useful disclosure, but it neither verifies their licenses independently nor establishes which pharmacy will fill a particular prescription.

The advertised sequence is questionnaire, clinician assessment and pharmacy fulfillment if approved. The telehealth consent describes asynchronous encounters using questionnaires and messages, with a real-time visit when state law requires it. It describes the practitioner as a nurse practitioner; that is the company’s representation, not our verification of an assigned clinician’s credentials. Before joining, establish how to reach the treating professional, expected response times and the process for refill review or concerns between shipments. The consent expressly says personal data is not monitored around the clock. The terms require users to be at least eighteen. The consent lists Arizona, Connecticut, Florida, Georgia, Iowa, Washington, Kentucky, Minnesota, North Carolina, Oklahoma, Tennessee, Texas and the District of Columbia. Treat this as the company’s stated service footprint and confirm the specific treatment at your physical location. A BMI calculator explains weight categories but does not establish a numerical prescribing threshold. An intake or promotional same-day approval message cannot guarantee eligibility, a prescription or a dispatch date.

The homepage advertises semaglutide starting at $135 monthly and tirzepatide at $165 monthly, each labeled as a three-month plan with any-dose wording. A semaglutide tablet is advertised from $279 monthly on a one-month plan. These are different commitments, not directly comparable standalone monthly subscriptions. The public FAQ says pricing includes the medical visit, ongoing medication shipments and provider messaging. A complete initial charge, supply schedule, renewal ladder and cancellation cutoff were not established from the public pages. Ask for all of them in writing, including whether the three-month price means an upfront purchase or installments, what happens after that period and whether taxes or additional services apply. The terms describe self-pay treatment and say affiliated providers and pharmacies will not bill insurance. Do not assume submitting the receipt will produce reimbursement. The most important purchasing issue is the money-back banner. It conflicts with the terms and shipping policy, which describe prescription sales as final and exclude refunds on dispensed, mixed or purchased medication. The banner does not explain an exception that reconciles those rules. Obtain the specific refund available after denial, clinician review, pharmacy preparation and dispatch before payment. Stopping marketing texts is not a subscription-cancellation procedure. Delivery timing also varies materially across pages: the homepage mentions one to three days and its FAQ two to five, while the shipping policy gives one to two business days processing and a four-to-twelve-business-day shipping period. The terms give still longer processing and shipping windows. Request the actual schedule for your prescription rather than planning around the shortest promise. Retain packaging and ask both pharmacy and support how to handle an incorrect or damaged order; the shipping policy directs carrier claims and makes no broad replacement promise.

The homepage specifically identifies compounded semaglutide and compounded tirzepatide, and separately markets a semaglutide tablet. It does not establish a branded oral product for that tablet offer. Compounded products are not FDA-approved; company references to pharmacy oversight or branded-drug studies do not change the approval status of the preparation supplied. FDA recommends compounded GLP-1 medicines only when an approved medicine cannot meet the patient’s medical needs. Ask the clinician to explain that rationale and provide the exact formulation, ingredients, concentration and pharmacy. The advertised oral route should not inherit the instructions, approval or expected outcomes of branded injectable semaglutide or a branded tablet. For injections, request label-matched dose measurements and storage instructions, including what to do if a shipment arrives outside its required conditions. Testimonials, before-and-after photographs and general benefit claims cannot establish your outcome or comparative quality of this service.